That the government’s fiscal deficit is narrowing in spite of an economic slowdown is commendable. The heavy lifting to support growth will have to be done by RBI via policy rate cuts.

The U.S. Food and Drug Administration (FDA) recently issued two new guidance documents governing details of the Accelerated Approval ...